MedTrace Logo

Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis

NCT03858426 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-02-28

No results posted yet for this study

Summary

1. Registry of demographic, clinical, endoscopic and histological data at baseline.
2. Registry of patients treated with PPI:

* Clinical, endoscopic and histological response at 8-12 weeks of induction treatment
* Clinical, endoscopic and histological response at 6 and 12 months weeks of maintenance treatment
3. Registry of patients treated with two foods elimination diet:

* Clinical, endoscopic and histological response at 8-12 weeks of induction treatment
* Identification of food trigger: milk, gluten or milk and gluten
* Clinical, endoscopic and histological response at one year elimination of food trigger
* Registry of adverse events
4. Registry of patients treated with swallowed steroids (budesonide or fluticasone):

* Clinical, endoscopic and histological response at 8-12 weeks of induction treatment
* Clinical, endoscopic and histological response at 6 months of maintenance steroid treatment
* Registry of adverse events

Conditions

  • Eosinophilic Esophagitis

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-11-01
Completion
2022-07-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858426 on ClinicalTrials.gov